# A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Orally Inhaled Aerosolized Hydroxychloroquine Sulfate in Healthy Adult Volunteers

> **NCT04461353** · PHASE1 · COMPLETED · sponsor: **Pulmoquine Therapeutics, Inc** · enrollment: 12 (actual)

## Conditions studied

- Severe Acute Respiratory Syndrome Coronavirus 2

## Interventions

- **DRUG:** Aerolized Hydroxychloroquine Sulfate
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04461353
- **Lead sponsor:** Pulmoquine Therapeutics, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-25
- **Primary completion:** 2020-08-17
- **Final completion:** 2020-08-17
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2020-10-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04461353

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04461353, "A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Orally Inhaled Aerosolized Hydroxychloroquine Sulfate in Healthy Adult Volunteers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04461353. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*